Back to results
Active, not recruitingPhase 2

A Study to Evaluate the Safety and Biomarker Effects of RO7269162 in Participants at Risk for or at the Prodromal Stage of Alzheimer's Disease (AD)

NCT06402838

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Centro de Investigación Clínica UC-CICUC

Santiago, Chile

+46 additional locations

View on ClinicalTrials.gov